These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6852116)

  • 21. Uptake of [3H]nitrendipine into cardiac and smooth muscles.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1983 May; 32(10):1660-3. PubMed ID: 6860353
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
    Bolger GT; Skolnick P
    Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
    Schwartz J; Velly J
    Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High affinity binding of a calcium channel antagonist to smooth and cardiac muscle.
    Bolger GT; Gengo PJ; Luchowski EM; Siegel H; Triggle DJ; Janis RA
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1604-9. PubMed ID: 7073757
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
    Kosinski C; Gross G; Hanft G
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ontogeny of specific binding sites for the calcium channel antagonist, nitrendipine, in mouse heart and brain.
    Erman RD; Yamamura HI; Roeske WR
    Brain Res; 1983 Nov; 278(1-2):327-31. PubMed ID: 6640324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive, kinetic measurements of [3H]nitrendipine binding to isolated rat myocytes by condensed phase radioluminescence.
    von Tscharner V; Bailey IA
    FEBS Lett; 1983 Oct; 162(1):185-8. PubMed ID: 6617891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H]nitrendipine binding and calcium and sodium fluxes in brain.
    Harris RA; Jones SB; Bruno P; Bylund DB
    Biochem Pharmacol; 1985 Jun; 34(12):2187-91. PubMed ID: 3159390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of dihydropyridine binding sites in the rat brain: hypertension and age-dependent modulation of [3H](+)-PN 200-110 binding.
    Huguet F; Huchet AM; Gerard P; Narcisse G
    Brain Res; 1987 May; 412(1):125-30. PubMed ID: 2955850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
    Thorgeirsson G; Rudolph SA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo identification of calcium antagonist binding sites using [3H]nitrendipine.
    Schoemaker H; Lee HR; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1983 Mar; 88(2-3):275-6. PubMed ID: 6852115
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
    Garthoff B; Bellemann P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S36-9. PubMed ID: 2455136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 125I-endothelin-1 binding to brain and cardiac membranes from normotensive and spontaneously hypertensive rats.
    Gu XH; Casley DJ; Cincotta M; Nayler WG
    Eur J Pharmacol; 1990 Feb; 177(3):205-9. PubMed ID: 2155810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of ventricular sarcolemmal membranes does not alter binding properties of nitrendipine.
    Hayes JS; Bowling N; Conery BG; Kauffman RF
    Biochim Biophys Acta; 1985 Jan; 812(2):313-20. PubMed ID: 3155624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
    J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.